CJC-1295 no DAC 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of CJC-1295 no DAC supplied by Grail Formula undergoes independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety. Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, spectrometric and mass spectrometry techniques. Batch: GF-CJCND-B241 Key analytical results include:

• Assay Content: 11.24 mg
• Identification – Retention Time: 0.996
• Identification – FTIR Spectrum: 992
• Molecular Ion Mass Identification: 3367 Da
• Purity: 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium. These analytical procedures provide confirmation of identity, purity, batch consistency and laboratory-grade research quality.

Product Overview

CJC-1295 no DAC is a synthetic peptide research compound widely studied in controlled laboratory environments focused on growth hormone signalling pathways, peptide-receptor interactions and endocrine regulatory mechanisms. The compound is commonly referred to as MOD GRF (1-29) and represents a modified growth hormone releasing factor analogue developed for peptide research applications. This preparation contains 10 mg of high-purity lyophilized peptide supplied in a sealed research vial. Lyophilization helps preserve compound stability during storage and allows researchers to reconstitute the peptide for controlled in vitro experimentation. Due to its well-characterised structure and extensive presence in scientific literature, CJC-1295 no DAC remains one of the most frequently referenced peptide compounds within endocrine and signalling pathway research.

Peptide Overview

CJC-1295 no DAC is a modified analogue of growth hormone releasing factor (GRF) designed for research applications involving peptide-mediated signalling systems. Within experimental models, the peptide is commonly investigated for its interaction with growth hormone releasing hormone receptors and related intracellular signalling pathways. The compound has attracted significant scientific interest because of its defined molecular structure, receptor specificity and suitability for controlled laboratory studies examining peptide-regulated biological processes. Researchers frequently utilise CJC-1295 no DAC in studies exploring signalling cascades, receptor binding dynamics and endocrine communication networks.

Historical Background and Scientific Context

Research into growth hormone releasing factors expanded significantly during the late twentieth century as scientists sought to better understand the hormonal mechanisms involved in growth hormone regulation. Advances in peptide synthesis technology enabled the development of modified GRF analogues with improved stability characteristics suitable for laboratory investigation. CJC-1295 no DAC emerged from this scientific effort and became a frequently utilised research compound for studying receptor-mediated signalling systems and endocrine regulatory mechanisms. Over time, the peptide has been incorporated into numerous experimental models examining hormone signalling, receptor activation and peptide-mediated communication pathways.

Mechanistic Focus in Research

Within controlled laboratory settings, CJC-1295 no DAC is commonly studied in relation to peptide-mediated signalling networks and receptor interaction mechanisms. Research investigations frequently explore the compound in experimental models examining:

• Growth hormone releasing hormone receptor signalling
• Peptide-receptor interaction dynamics
• Intracellular signalling cascades
• Endocrine regulatory networks
• Peptide-mediated communication pathways
• Molecular signalling pathway analysis
• Comparative peptide research models

These experimental approaches allow researchers to investigate molecular processes associated with peptide signalling and receptor-mediated biological regulation.

Research Applications

In controlled research environments, CJC-1295 no DAC may be utilised in experimental models designed to investigate peptide signalling systems and endocrine regulatory mechanisms. Examples of research applications include:

• Growth hormone signalling pathway research
• Peptide receptor interaction studies
• Endocrine system modelling
• Molecular signalling investigations
• Comparative peptide compound studies
• Cell signalling pathway analysis
• Controlled in vitro peptide research

These applications are conducted exclusively within laboratory environments and are intended to improve scientific understanding of peptide-mediated biological processes.

Grail Formula Quality

Every Grail Formula research compound is produced and handled according to strict quality standards designed to support reliable laboratory experimentation. Each batch undergoes comprehensive independent analytical testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity confirmation
• Molecular mass verification
• Microbial safety screening
• Endotoxin analysis
• Heavy metal screening
• Full batch traceability

Independent laboratory verification provides researchers with transparent analytical data and confidence in the consistency of the supplied research material.

When You Choose Grail Formula

When selecting Grail Formula, researchers gain access to independently verified research compounds supported by extensive analytical documentation and batch-specific testing. Our commitment to transparency includes publication of assay results, purity verification, identity confirmation, endotoxin testing, microbial screening and elemental impurity analysis. Every batch is supported by a downloadable Certificate of Analysis, providing full traceability and independent verification from Liquilabs s.r.o. Czechia.

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.8 % purity confirmed by COA
• Assay content verified at 11.24 mg
• Molecular ion mass identified at 3367 Da
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• MOD GRF (1-29) peptide research compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.